Reliability of multi-modal MRI-derived brain phenotypes for multi-site assessment of neuropsychiatric complications of SARS-CoV-2 infection
Eugene Duff, Fernando Zelaya, Fidel Alfaro Almagro, Karla L Miller, Naomi Martin, Thomas E. Nichols, Bernd Taschler, Ludovica Griffanti, Christoph Arthofer, Chaoyue Wang, Richard A.I. Bethlehem, Klaus Eickel, Matthias Günther, David K Menon, Guy Williams, Bethany Facer, Greta K Wood, David J Lythgoe, Flavio Dell’Acqua, Steven CR Williams, Gavin Houston, Simon Keller, Gerome Breen, Benedict D Michael, Peter Jezzard, Stephen M Smith, Edward T. Bullmore On behalf of the COVID-CNS Consortium
doi: https://doi.org/10.1101/2021.10.13.21264967
Eugene Duff
1Wellcome Centre for Integrative Neuroimaging (WIN FMRIB), University of Oxford, Oxford, United Kingdom
2Department of Paediatrics, University of Oxford, Oxford, United Kingdom
3UK Dementia Research Institute, Department of Brain Sciences, Imperial College London, London, United Kingdom
Fernando Zelaya
4Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, United Kingdom
Fidel Alfaro Almagro
1Wellcome Centre for Integrative Neuroimaging (WIN FMRIB), University of Oxford, Oxford, United Kingdom
Karla L Miller
1Wellcome Centre for Integrative Neuroimaging (WIN FMRIB), University of Oxford, Oxford, United Kingdom
Naomi Martin
5Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, United Kingdom
Thomas E. Nichols
6Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom
1Wellcome Centre for Integrative Neuroimaging (WIN FMRIB), University of Oxford, Oxford, United Kingdom
Bernd Taschler
1Wellcome Centre for Integrative Neuroimaging (WIN FMRIB), University of Oxford, Oxford, United Kingdom
Ludovica Griffanti
1Wellcome Centre for Integrative Neuroimaging (WIN FMRIB), University of Oxford, Oxford, United Kingdom
7Wellcome Centre for Integrative Neuroimaging, Oxford Centre for Human Brain Activity, Department of Psychiatry, University of Oxford, Oxford, United Kingdom
Christoph Arthofer
1Wellcome Centre for Integrative Neuroimaging (WIN FMRIB), University of Oxford, Oxford, United Kingdom
Chaoyue Wang
1Wellcome Centre for Integrative Neuroimaging (WIN FMRIB), University of Oxford, Oxford, United Kingdom
Richard A.I. Bethlehem
8Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom
Klaus Eickel
9mediri GmbH, Heidelberg, Germany
Matthias Günther
9mediri GmbH, Heidelberg, Germany
10University Bremen, Bremen, Germany
11Fraunhofer MEVIS, Bremen, Germany
David K Menon
12Division of Anaesthesia, University of Cambridge, Cambridge, United Kingdom
Guy Williams
13Wolfson Brain Imaging Centre, Department of Clinical Neurosciences, University of Cambridge, United Kingdom
Bethany Facer
14Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom
Greta K Wood
14Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom
David J Lythgoe
4Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, United Kingdom
Flavio Dell’Acqua
4Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, United Kingdom
15NatBrainLab, Department of Forensics and Neurodevelopmental Sciences, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, United Kingdom
16Sackler Institute for Translational Neurodevelopment, Institute of Psychiatry Psychology and Neuroscience, King’s College London, UK
Steven CR Williams
4Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, United Kingdom
Gavin Houston
13Wolfson Brain Imaging Centre, Department of Clinical Neurosciences, University of Cambridge, United Kingdom
Simon Keller
14Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom
Gerome Breen
5Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, United Kingdom
Benedict D Michael
17Clinical Infection Microbiology and Immunology, Institute of Infection, Veterinary and Ecological Sciences, Liverpool, United Kingdom
Peter Jezzard
1Wellcome Centre for Integrative Neuroimaging (WIN FMRIB), University of Oxford, Oxford, United Kingdom
Stephen M Smith
1Wellcome Centre for Integrative Neuroimaging (WIN FMRIB), University of Oxford, Oxford, United Kingdom
Edward T. Bullmore
8Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom
13Wolfson Brain Imaging Centre, Department of Clinical Neurosciences, University of Cambridge, United Kingdom
Data Availability
All data produced in the present study will be made openly available when the paper has been peer-reviewed.
Posted October 14, 2021.
Reliability of multi-modal MRI-derived brain phenotypes for multi-site assessment of neuropsychiatric complications of SARS-CoV-2 infection
Eugene Duff, Fernando Zelaya, Fidel Alfaro Almagro, Karla L Miller, Naomi Martin, Thomas E. Nichols, Bernd Taschler, Ludovica Griffanti, Christoph Arthofer, Chaoyue Wang, Richard A.I. Bethlehem, Klaus Eickel, Matthias Günther, David K Menon, Guy Williams, Bethany Facer, Greta K Wood, David J Lythgoe, Flavio Dell’Acqua, Steven CR Williams, Gavin Houston, Simon Keller, Gerome Breen, Benedict D Michael, Peter Jezzard, Stephen M Smith, Edward T. Bullmore
medRxiv 2021.10.13.21264967; doi: https://doi.org/10.1101/2021.10.13.21264967
Reliability of multi-modal MRI-derived brain phenotypes for multi-site assessment of neuropsychiatric complications of SARS-CoV-2 infection
Eugene Duff, Fernando Zelaya, Fidel Alfaro Almagro, Karla L Miller, Naomi Martin, Thomas E. Nichols, Bernd Taschler, Ludovica Griffanti, Christoph Arthofer, Chaoyue Wang, Richard A.I. Bethlehem, Klaus Eickel, Matthias Günther, David K Menon, Guy Williams, Bethany Facer, Greta K Wood, David J Lythgoe, Flavio Dell’Acqua, Steven CR Williams, Gavin Houston, Simon Keller, Gerome Breen, Benedict D Michael, Peter Jezzard, Stephen M Smith, Edward T. Bullmore
medRxiv 2021.10.13.21264967; doi: https://doi.org/10.1101/2021.10.13.21264967
Subject Area
Subject Areas
- Addiction Medicine (373)
- Allergy and Immunology (690)
- Anesthesia (184)
- Cardiovascular Medicine (2760)
- Dermatology (236)
- Emergency Medicine (414)
- Epidemiology (12413)
- Forensic Medicine (10)
- Gastroenterology (784)
- Genetic and Genomic Medicine (4272)
- Geriatric Medicine (396)
- Health Economics (702)
- Health Informatics (2761)
- Health Policy (1021)
- Hematology (370)
- HIV/AIDS (880)
- Medical Education (404)
- Medical Ethics (112)
- Nephrology (454)
- Neurology (4054)
- Nursing (218)
- Nutrition (600)
- Oncology (2134)
- Ophthalmology (607)
- Orthopedics (251)
- Otolaryngology (313)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (479)
- Pediatrics (1150)
- Primary Care Research (470)
- Public and Global Health (6663)
- Radiology and Imaging (1452)
- Respiratory Medicine (886)
- Rheumatology (422)
- Sports Medicine (353)
- Surgery (465)
- Toxicology (57)
- Transplantation (192)
- Urology (171)